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Abstract Anion channels in human mesothelial and mesothe-
lioma cell lines were characterized by patch-clamp and biomo-
lecular approaches. We found an outwardly rectifying anionic
current which was inactivated at positive voltages and inhibited
by extracellular adenosine 5P-triphosphate (ATP). Mesothelial
and mesothelioma cells behaved di¡erently concerning current
inactivation properties. Inactivation is more pronounced and has
a steeper onset in mesothelial cells. Di¡erent reversal potentials,
in asymmetrical Cl3 solutions, that could be attributed to a
di¡erent selectivity of the channel, have been observed in the
two cell lines. Mesothelioma cell single-channel analysis indi-
cates that the number of the same active anion channel (3^4
pS) increased under hypoosmotic conditions. Immunocyto-
chemistry experiments showed the presence of ICln protein in
the cytosol and in the plasma membrane. Western blot analysis
revealed an increase of ICln in the membrane under hypotonic
conditions, an event possibly related to the activation of Cl3
channels.
+ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Pleural mesothelial and mesothelioma cells lack an exten-
sive electrophysiological characterization, and up to now there
are no data about Cl3 channels. However, the active role of
mesothelial cells in water, small solutes and protein transport
from the pleural space [1] suggests the presence of anionic
conductances. Cl3 channels are known to take part in the
transepithelial transfer of solutes and water in epithelia [2] ;
besides playing a relevant role in ionic homeostasis and in cell
volume control (i.e. regulatory volume decrease, RVD) [3].
Channels involved in RVD may participate in proliferation
and migration of tumor cells by regulating the cell cycle prog-
ress [4] with an active volume modulation. Dysfunctions in-
volving ionic channels, particularly Cl3 channels activated
upon hypotonic cell swelling, have been correlated with pro-
liferative and migratory capacity of neoplastic cells [5,6]. RVD
channel (RVDC) blockers are potent inhibitors of angiogene-
sis [7] and they have been shown to stop the proliferation of
cervical cancer cells in the G0/G1 stage [8] and the invasive
migration of glioma cells [9]. Recent data show an upregula-
tion of anionic mitochondrial channels (VDAC) in mesothe-
lioma cells compared to mesothelial cells [10].
The aim of this study was the characterization of Cl3 chan-
nels in mesothelioma and mesothelial cells of human pleura to
elucidate their function in solute transport and in cellular ion
and volume homeostasis to get some evidences about di¡er-
ences related to the occurrence of the mesothelioma.
2. Materials and methods
2.1. Drugs and chemicals
RPMI 1640 (Roswell Park Memorial Institute) medium, Medium
199 HEPES modi¢cation, DMEM (Dulbecco’s modi¢ed essential me-
dium), PBS (phosphate bu¡ered saline), HEPES (N-[2-hydroxyethyl]-
piperazine-NP-[2-ethanesulfonic acid]), TES (N-Tris[hydroxymethyl]-
methyl-2-aminoethane-sulfonic acid), NMG (N-methyl-D-glucamine),
EDTA (ethylenediamine tetraacetic acid), EGTA (ethyleneglycol-bis-
[aminoethylether]-N,N,NP,NP-tetraacetic acid), TEACl (tetraethylam-
monium chloride), ATP (adenosine 5P-triphosphate), NPPB (nitrophe-
nylpropylamino benzoate) were purchased from Sigma (St. Louis,
MO, USA).
2.2. Mesothelioma and mesothelial cell line
Mesothelioma cells were obtained from pleural e¡usions of patients
with histologically demonstrated pleural malignant mesothelioma.
Pleural e¡usions surgically obtained were centrifuged (200Ug, at
20‡C for 10 min) and cell pellets were treated with erythrocyte lysis
bu¡er (ammonium chloride 0.829%, potassium bicarbonate 0.1%,
EDTA 0.0037%) and seeded into 25 cm2 tissue culture £asks. Cells
were cultured in RPMI medium with 15% fetal bovine serum, 2 mM
glutamine, 10 mM HEPES bu¡er, 100 U/ml penicillin, 100 Wg/ml
streptomycin, 0.25 Wg/ml amphotericin. Cultures were maintained in
humidi¢ed atmosphere of 5% CO2 at 37‡C. When cells reached con-
£uence, 1 min trypsin (0.25%)^EDTA (0.03%) treatment was used to
detach the cells which were then reseeded at high density. Cell lines
were considered established between the 15th and 30th passages. All
the cell lines had the immunocytological characteristics of mesothelial
cells: coexpression of low molecular weight cytokeratins, vimentin
and Calretinin and negative reactivity with antibody to carcinoem-
bryonic antigen (CEA) and thyroid transcription factor (TTF)-1
[11]. Specimens were also examined by electron microscopy for char-
acteristic microvilli and intermediate ¢laments. The MeT-5A cell line
(ATCC-LGC Promochem, UK) was produced from cells in the pleu-
ral £uids obtained from non-cancerous individuals. The cells were
grown in culture £asks in Medium 199 containing 0.4 WM hydrocor-
tisone, 0.87 WM zinc-free insulin, 3.3 nM epidermal growth factor,
0.05 mg/ml gentamicin, 5% fetal bovine serum. Subcultures were rou-
tinely established every third to fourth day by trypsin (0.25%)^EDTA
(0.03%) treatment.
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2.3. Solutions for cell maintenance
During the patch-clamp experiments (before the seal formation)
cells were maintained in a DMEM solution bu¡ered using 10 mM
TES or, when speci¢ed, in Krebs^Henseleit solution containing
(mM): 110 NaCl; 4.7 KCl; 1.2 MgSO4 ; 1.2 KH2PO4 ; 2.5 CaCl2 ;
10 TES; 5 glucose; 50 mannitol (pH 7.4); the quantity of mannitol
was changed (0^50 mM) to obtain hypotonic and isotonic solutions,
respectively.
2.4. Solutions for whole-cell con¢guration
The micropipette solution contained (mM): 108 NMGCl, 30
TEACl, 5 glucose, 10 HEPES/NMG (pH 7.2), 4 Mg^ATP, 1.9 CaCl2
and 3 EGTA (free [Ca2þ] of 2U1037 M). The symmetrical extracel-
lular solution contained (mM): 113 NMGCl, 1.8 CaCl2, 1 MgCl2, 30
TEACl, 5 glucose, 10 HEPES/NMG (pH 7.4). NMGgluconate re-
placed NMGCl in Cl3 asymmetrical solution. In experiments for vol-
ume regulation the micropipette solution contained (mM): 90
NMGCl, 30 TEACl, 5 glucose, 10 HEPES/NMG (pH 7.2), 4 Mg^
ATP, 50 mannitol, 1.9 CaCl2 and 3 EGTA (free [Ca2þ] of 2U1037
M). The extracellular solution was (mM): 90 NMGCl, 1.8 CaCl2,
1 MgCl2, 30 TEACl, 5 glucose, 10 HEPES/NMG (pH 7.4) and 0,
50 or 100 mM mannitol was added to obtained hypotonic, isotonic
and hypertonic solutions, respectively.
2.5. Solutions for single-channel recording
In cell-attached con¢guration the bath solution was an iso- or hy-
potonic Krebs^Henseleit. The micropipette solution (cell-attached and
inside-out con¢gurations) contained (mM): 90 NMGCl, 30 TEACl,
1.8 CaCl2, 1 MgCl2, 5 glucose, 10 HEPES/NMG (pH 7.4), 50 man-
nitol. In inside-out con¢guration the bath symmetrical solution con-
tained (mM): 90 NMGCl, 30 TEACl, 1.9 CaCl2, 3 EGTA, 5 glucose,
10 HEPES/NMG (pH 7.2), 50 mannitol. In the bath asymmetrical
solution the 90 mM NMGCl was substituted with NMGgluconate.
2.6. Solutions for current-clamp experiments
Bath solution was an iso- or hypotonic Krebs^Henseleit solution.
The micropipette solution contained (mM): 20 NaCl, 20 KCl, 100
Kgluconate, 1 CaCl2, 2 EGTA, 10 HEPES/NMG (pH 7.2), 5 glucose,
4 Mg^ATP.
2.7. Patch-clamp technique
Patch-clamp technique and relative statistics were applied as re-
ported [12]. In whole-cell con¢guration the resistances of the micro-
electrodes (RWel) and of the seals (Rs) were 2^8 M6 and 1^2 G6
respectively. Signals were ¢ltered at 5 kHz with an eight-pole Bessel
¢lter. In single-channel recording the RWel was 15^18 M6, and Rs was
15^50 G6. Signals were ¢ltered at 0.2 kHz (eight-pole Bessel ¢lter). In
whole-cell and cell-attached con¢gurations, potential di¡erences were
expressed as overall potential di¡erences, considering the junction
potential, the holding potentials and cell membrane potential (pdcm)
(cell-attached only). The bath was grounded with an Ag/AgCl elec-
trode immersed in a 3 M KCl agar bridge.
2.8. Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was isolated from MeT-5A and mesothelial cells by
using RNeasy protect kit (Qiagen, Italy), according to manufacturer’s
instructions. 2^5 Wg of total RNA were used for the ¢rst strand cDNA
synthesis with Superscript II RT (Invitrogen, Italy) according to man-
ufacturer’s instruction. The primer pairs used in the PCR reaction
were 5P-CGAATTCTCGAGATGAGCTTCCTCAAAAGTTTCCC-
G-3P, 5P-GGAATTCGGTCCTCAGTGATCAACATCTGCATCCT-
C-3P for ICln. The PCR fragments were extracted from agarose gels
(gel extraction kit, Qiagen, Italy), ligated into pSTblue1 vector (No-
vagen, Italy) and double strand sequenced in a Li-Cor Gene ReadIR
4200 automatic sequencer (MWG, Germany). Bioedit alignment pro-
gram and BLAST protein database search program were used for the
analysis of sequence similarities.
2.9. Western blot experiments
For total protein extraction cells from a 10 cm plate were lysed in
1 ml of lysis bu¡er (20 mM Tris^HCl pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% NP40, 10 Wg/ml aprotinin, 0.2 mM phenylmethylsulfonyl
£uoride (PMSF)) and centrifuged at 4‡C for 30 min at 10 000Ug.
Supernatant was recovered and protein concentration measured using
the Bradford method.
Cytosol and membrane protein were separated by Triton X-114-
based lysis solution as reported by Musch and coworkers [13]. Pro-
teins were resolved on a 12% sodium dodecyl sulfate (SDS)^polyac-
rylamide gel, and electrophoretically transferred to Immuno-Blot1
polyvinylidene di£uoride (PVDF) membranes (Bio-Rad Laboratories,
Italy). The membranes were quenched in blocking solution overnight
(5% non-fat dried milk, 50 mM Tris, pH 7.5, 100 mM NaCl, and 0.1%
Tween 20) and incubated with a polyclonal antibody to ICln [14],
diluted respectively 1:700 or 1:200 in the blocking solution. The
bound antibody was detected by the enhanced chemiluminescence
procedure (Amersham Corp.) using horseradish peroxidase-conju-
gated goat anti-rabbit IgG diluted 1:20 000.
In the experiments aimed at determining the ratio between the
cytosolic and membrane fractions from cells under hypotonic or nor-
mal conditions, the densitometric analysis was conducted in a blinded
fashion by two researchers who independently chose the regions of
interest analyzing Western blot signals of cell fractions obtained from
the same cell plate. Chosen areas were numerically integrated and
measured with the Image Tool 3.00 software.
2.10. Immunocytochemistry
Cells were grown on coverslips to approximately 70% of con£uence,
¢xed in a PBS (50 mM phosphate bu¡er, 150 mM NaCl) containing
3% paraformaldehyde and permeabilized with PBS containing 0.1%
Triton X-100 for 3 min at room temperature. Cells were blocked with
3% bovine serum albumin (BSA) in PBS for 1 h and incubated over-
night at 4‡C with anti-ICln antibody at 1:100 dilution in PBS con-
taining 0.1% BSA. After washing out of the primary antibody, cells
were incubated for 1 h with Cy12-conjugated anti-rabbit antibody
(Jackson Immunoresearch Laboratories). Cells were imaged using a
Leica TCS-NT (Leica Microsystems, Heidelberg, Germany) confocal
laser scanning microscope, equipped with laser argon/krypton, 75 mW
multiline. Focal series of horizontal planes of section were monitored
for £uorescein isothiocyanate (FITC) by means of the 488 and 568 nm
laser lines, and a FITC band pass 590/30 ¢lter.
2.11. Statistics
The experimental values are expressed as meanTS.E.M. of n ex-
periments. Student’s t-test was used (with unpaired data unless other-
wise speci¢ed) for the statistical analysis. The value of Ps 0.05 is
indicated by not signi¢cant (ns). Best ¢ttings were performed by linear
and non-linear regression analyses.
3. Results
We performed whole-cell patch-clamp experiments with
symmetrical NMGCl solutions: the currents showed outward
recti¢cation and inactivation at voltages over +60 mV (Fig.
1B, E). In asymmetrical NMGCl solutions (Fig. 1C, E) the
reversal potential (Vrev) shifted from 0.75T 0.8 to 34.8T 1.8
mV, n=4 (P6 0.01, paired data), as expected for a Cl3 se-
lective channel (Pgluconate/PCl = 0.08T 0.02, n=4). The current
was inhibited by 1034 M NPPB of about 90% at all voltages
(P6 0.05, paired data, Fig. 1D, E).
Similar results concerning the Cl3 selectivity, the amplitude
and the NPPB sensitivity of the measured current were ob-
tained under the same conditions using MeT-5A cells
(30.586T 0.095 nA, n=9, at 394 mV; 0.868T 0.154 nA,
n=9, at 86 mV; 90% of inhibition due to 1034 M NPPB at
86 mV). Vrev shifted from 0.8T 0.8 to 25.4T 2.0 mV, n=9, in
asymmetrical NMGCl solutions (P6 0.01); this last Vrev was
lower than that determined in mesothelioma cells (P6 0.05).
Ratios between the currents values measured at the beginning
(Ii) and at the end (If ) of voltage steps (Fig. 1F) changed with
the di¡erent cell types. Monoexponential ¢tting of the cur-
rents recorded at voltages of 80 and 100 mV revealed di¡erent
inactivation time constants (0.82T 0.01 s, n=9, vs. 2.05T 0.33
s, n=4 at 80 mV, P6 0.05, and 0.80T 0.01 s, n=9, vs.
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1.69T 0.18 s, n=4 at 100 mV, P6 0.05, for mesothelial and
mesothelioma cells, respectively).
The tracings (Fig. 2B) and the I/V relationship (Fig. 2D)
show an increase of currents (whole-cell con¢guration) when
the hypotonic solution replaced the isotonic one. 1034 M
NPPB in the hypotonic extracellular medium induced a 90%
decrease of the current at all voltages (from 5.87T 0.51 to
0.31T 0.15 nA at 102 mV, n=18, P6 0.01). Extracellular
ATP (10 mM), usually a voltage-dependent inhibitor of
RVDC [15], reduced the swelling-induced current at positive
voltages (Fig. 2C, D). In presence of the hypertonic extracel-
lular solution, the current decreased (from 1.16T 0.21 nA
under isotonic condition, to 0.63T 0.16 nA, +82 mV, n=9,
P6 0.05).
Fig. 3A shows single-channel tracings obtained in cell-at-
tached con¢guration (isotonic extracellular solution) on hu-
man mesothelioma cells. In current-clamp condition the
pdcm was 336.2 T 3.8 mV in isotonic extracellular solution,
and 331.2T 2.3 mV 3^5 min after the substitution with the
hypotonic solution (P6 0.05, n=8). The single-channel I/V
Fig. 1. Cl3 currents in mesothelioma cell line, whole-cell con¢gura-
tion. A: Stimulation protocol. B: Whole-cell currents in symmetrical
NMGCl solutions, C: asymmetrical NMGCl solutions (25.6 mM
[Cl3] in the bath) and D: in presence of 1034 M NPPB. E: Cur-
rent^voltage (I/V) relationship in NMGCl symmetrical and asym-
metrical solutions and NPPB e¡ects: F symmetrical solutions, R
asymmetrical solutions, a 1034 M NPPB, E recovery in symmetrical
solutions (meansTS.E.M., n=4). F: Current inactivation analysis
(symmetrical NMGCl solutions): ratio between initial currents (Ii)
(at 10 ms to starting of pulse) and ¢nal currents (If ) (at 1980 ms to
starting of pulse): 8 mesothelial cells, 7 mesothelioma cells; means
TS.E.M. (n=9 and n=4, respectively); *P9 0.05 in F.
Fig. 2. Osmolarity e¡ect on mesothelioma cell lines, whole-cell con-
¢guration. A: Protocol applied. B: Current recorded in hypotonic
medium and C: extracellular ATP. D: Current^voltage (I/V) rela-
tionship in hypotonic medium in absence/presence of extracellular
10 mM ATP (n=18). F Isotonic solution; R hypotonic solution;
U extracellular ATP; meansTS.E.M.; *P9 0.05 compared to the
hypotonic condition.
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relationship (isotonic extracellular solution, Fig. 3B) revealed
a single-channel conductance of 4.2 T 1.1 pS (at 45 mV, n=9).
The Vrev was 356.2 T 4.1 mV, a value corresponding to an
estimated intracellular Cl3 activity of about 15 mM. No sig-
ni¢cant voltage dependence of Po was observed (mean value
of Po 0.109T 0.018, n=9, between 3140 and 45 mV). The I/V
relationship in the hypotonic solution (Fig. 3B) showed a
di¡erent Vrev (337.6 T 6.0 mV, n=9, P6 0.05). The conduc-
tance (4.6 T 1.5 pS at 45 mV, n=9, ns) and the Po (mean value
of 0.137T 0.041, n=9, between 3140 and +45 mV, ns) were
similar to those observed under isotonic conditions, but the
number of activated channels in a patch was signi¢cantly in-
creased (P6 0.05, n=15, Fig. 3C, D). The nature of the chan-
nel was con¢rmed by inside-out experiments (Fig. 3E, F). In
presence of symmetrical NMGCl solutions the I/V relation-
ship (Fig. 3F) was outwardly rectifying. The conductance was
1.7T 0.4 pS, n=6 (at 100 mV, ns from that in cell-attached
con¢guration) and the Vrev was 32.2 T 2.5 mV, n=6 (ns from
0). Replacing NMGCl with a solution containing NMGgluc-
onate (Fig. 3F) we observed a shift of the Vrev (325.9T 5.5
mV, n=6, P6 0.05; Pgluconate/PCl = 0.21T 0.14, n=6).
We focused our attention on the ICln protein, one of the
possible candidates for the swelling-activated current (ICl;swell)
[3]. The expression of the protein was con¢rmed by RT-PCR
and by sequencing of PCR products; also Western blot, per-
formed on total cellular lysates kept under isotonic condi-
tions, revealed the presence of the protein (Fig. 4).
By using confocal microscopy and the same antibody used
in the Western blot experiments, we performed immuno£uo-
rescence tests with tumoral cells kept under isotonic condi-
tions (Fig. 5). In all cells £uorescence was visible in the cyto-
plasmic region, while almost no immunoreactivity was
detectable in the nucleus (Fig. 5A). At a higher magni¢cation
a clear signal was detectable also in, or near, the membrane
(Fig. 5B). Interestingly, in many cells additional patches of
intracellular £uorescence were also observed (Fig. 5C). Pres-
ence of the ICln protein both in the membrane and in the
cytosol was con¢rmed also by Western blot experiments per-
Fig. 3. Single-channel recordings in mesothelioma cell lines, cell-attached and inside-out con¢guration. A, C, E: Tracings observed at indicated
voltages in isotonic or hypotonic solutions and in inside-out con¢guration (isotonic solutions): individual channels are shown, i.e. 1 and 2,
0= closed state. B: Current^voltage (I/V) relationship in isotonic (F) and hypotonic (E) condition; meansTS.E.M. (n=9). D: Number of the
channels observed/number of patches (NC/p, n=15, * =P6 0.05 compared with isotonic condition). F: Current^voltage (I/V) relationship in in-
side-out con¢guration in symmetrical (b) and asymmetrical (a) NMGCl solutions; meansTS.E.M. (n=6).
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formed in parallel on protein preparations of the particulate
fraction and on the cytosolic fraction of the same cell popu-
lation (Fig. 6). The signal in the membrane fraction under
isotonic conditions increased after stressing the cells with a
10 min hypotonic shock in both cell types (Fig. 6).
4. Discussion
In mesothelioma cells, under isotonic conditions, the ob-
served single-channel current can justify the total Cl3 current
measured in whole-cell con¢guration. The biophysical and
pharmacological channel properties resemble those of the
anion channels responsible for the swelling-activated anion
current (ICl;swell) found in other cell types [16]. In particular,
single-channel data recall some characteristics of the ICln
protein reconstituted in lipid bilayers [17].
In both mesothelioma and mesothelial cells, Cl3 currents
inactivated at potentials over +60 mV, but with di¡erent ki-
netics. Inactivation is more pronounced, occurs earlier and
has a steeper onset in mesothelial cells. We also observed
di¡erent Vrev, in asymmetrical Cl3 solutions, that could be
attributed to a di¡erent selectivity of the channel. The phys-
iological meaning of these di¡erences is unclear but could be
related to the role of the RVD channel that is thought to be
involved in the proliferation and migration process in many
cell types. For instance, the proliferation rate of C6 glioma
cells, human cervical cancer cells and endothelial cells can be
blocked by inhibitors of RVDC [7,8,18] and the migration of
human glioma cells depends on the salt and water e¥ux
through the RVDC [9]. In other cell lines di¡erences in ionic
conductances (Cl3 in particular) between tumoral and non-
tumoral cells have been described and related to their poten-
tial in clinical diagnosis and therapy [19,20].
In mesothelioma cells the observed current under hypotonic
conditions (whole-cell con¢guration) increased up to 340%
and shared the same features of ICl;swell [3]. Presence of
RVDC was supported also by the extracellular ATP vol-
tage-dependent inhibition of the current [15] and the 50%
current decrease in hypertonic conditions [21]. Under hypo-
tonic conditions there was no change of single Cl3 channel
properties but for the increased number of active channels in
the single patch. All these data suggest that the same channel
population sustains the current under iso- and hypotonic con-
ditions.
In both mesothelial and mesothelioma cells RT-PCR and
Western blot experiments showed ICln expression; this pro-
tein is a candidate for the RVDC [3] as well as for the ob-
served currents in mesothelial cells. Fluorescence confocal mi-
croscopy and Western blot experiments revealed presence of
ICln in the cytosolic area of mesothelioma cells [14], but a
signal was present also at the plasmalemma level, in isotonic
conditions. However, these data cannot establish whether
ICln protein associates to or is inserted in the membrane.
The Western blot experiments also showed that the mem-
brane-associated ICln fraction increases after exposure of
the cells to a hypotonic shock, similarly to what has been
Fig. 4. RT-PCR and Western blot experiments performed on human
Met-5A and mesothelioma cells. A: RT-PCR products obtained
with ICln-speci¢c primers. A single band of the expected size (714
bp) was found for each cell. B: Western blot of cellular lysates
probed with an anti-ICln polyclonal antibody. HEK-293 cells (hu-
man embryonic kidney cells) were used as positive control.
Fig. 5. Localization of ICln in mesothelioma cells by immunocyto-
chemistry. Images were obtained by confocal microscopy. A:
1440U (pinhole 1) magni¢cation showing uniform staining of the
cytosol. B, C: 2880U (pinhole 0.43 and 0.7) magni¢cation showing
positive signals in correspondence of the cell membrane (B) and of
intracellular structures (C). D: Negative control obtained by omit-
ting the primary antibody (2880U (pinhole 0.8) magni¢cation).
Fig. 6. Western blot performed with an anti-ICln antibody on cyto-
solic (C) and particulate (M) fractions of human mesothelioma and
MeT-5A cells maintained in isotonic solutions (C1, M1) or chal-
lenged with a 10 min hypotonic stress (C2, M2).
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reported for rat myocytes [13] and for NIH ¢broblasts [14].
The mechanism by which ICln translocates to the membrane
has not been yet elucidated; it is believed that no vesicular
tra⁄cking event is involved [14,22].
In conclusion, our data show the presence of a RVDC,
which is active also in isotonic conditions in mesothelioma
cells. The number of active anion channels increases in hypo-
tonic conditions, in coincidence with an enhanced ICln ex-
pression in the cell membrane. This last event could be related
to the activation of the RVDC. Whether RVDC is due to or
regulated by ICln is still in debate [23,24]. Since RVDC may
be involved in the regulation of the cell cycle progress, in cell
migration and apoptosis [25] further investigations on di¡er-
ences between Cl3 channel properties in mesothelial or mes-
othelioma cells could prove useful in the diagnosis and/or
treatment of mesothelioma, a cancer type particularly resis-
tant to chemotherapy [26].
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